We have updated our Terms of Use.
Please read our new Privacy Statement before continuing.

Call in the doctor

29 Nov 2005 By Rob Cox

The drug company is acquiring its parent in a deal its billionaire founder says was negotiated at arm’s length. But that s not reflected in the valuation placed on the main asset being acquired. Sometimes it hurts to be a minority investor in the US.

This content is for Subscribers only


Email a friend

Please complete the form below.

Required fields *


(Separate multiple email addresses with commas)